Barbara Noiret,Florence Renaud,Guillaume Piessen et al.
Barbara Noiret et al.
Multicystic peritoneal mesothelioma (MCPM) is a particularly rare and benign neoplasm that arises from the peritoneum in reproductive aged females. Its etiopathogenesis is still unclear. The current prevailing theory supports the idea that ...
Constance Houlzé-Laroye,Clarisse Eveno
Constance Houlzé-Laroye
Background: Perforation of low-grade appendiceal mucinous neoplasms (LAMN) is characterized by its potential to spread mucin into peritoneal cavity, giving rise to pseudomyxoma peritonei, commonly treated with cytoreducti...
A real-time ex vivo model (eIBUB) for optimizing intraperitoneal drug delivery as an alternative to living animal models [0.03%]
一种实时体外模型（eIBUB），用于优化腹腔内药物输送以替代活体动物模型
Iaroslav Sautkin,Wiebke Solass,Frank-Jürgen Weinreich et al.
Iaroslav Sautkin et al.
Background: Optimization of intraperitoneal drug delivery systems requires functional models. We proposed the Inverted Bovine Urinary Bladder Model (IBUB), but IBUB does not allow repeated measurements over time and there...
CHIPOFIL: A pilot study assessing the feasibility of HIPEC without extracorporeal circuit [0.03%]
CHIP-OFIL研究：无体外循环行HIPEC可行性试点研究
Pablo Ortega-Deballon,Olivier Facy,Christine Binquet et al.
Pablo Ortega-Deballon et al.
Background: Heated intraperitoneal chemotherapy (HIPEC) is currently performed using an external circuit including a heating device and a pump. Available devices have several drawbacks in terms of costs, technique (flow s...
Early postoperative intraperitoneal chemotherapy for lower gastrointestinal neoplasms with peritoneal metastasis: a systematic review and critical analysis [0.03%]
早期腹腔内化疗对胃肠道肿瘤伴腹膜转移的应用：系统回顾和批判性分析
Mikael L Soucisse,Winston Liauw,Gabrielle Hicks et al.
Mikael L Soucisse et al.
Background: Early postoperative intraperitoneal chemotherapy (EPIC) can be used in combination with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) to treat patients with peritoneal carci...
Morbidity and mortality in women with advanced ovarian cancer who underwent primary cytoreductive surgery compared to cytoreductive surgery for recurrent disease: a meta-analysis [0.03%]
初次细胞减灭术与复发性卵巢癌患者的细胞减灭术的预后比较：一项荟萃分析
Helena C Bartels,Ailin C Rogers,James Postle et al.
Helena C Bartels et al.
Background: The primary treatment for advanced ovarian cancer is aggressive cytoreductive surgery (CRS), which is associated with considerable morbidity. The aim of this meta-analysis is to compare morbidity associated wi...
Bidirectional chemotherapy allowing surgery and HIPEC for malignant peritoneal mesothelioma [0.03%]
用于恶性腹膜间皮瘤的可手术和HIPEC的双向化疗
Barbara Noiret,Clarisse Eveno
Barbara Noiret
Background: This case report aims to describe the impact of the bidirectional chemotherapy (BDC) on resecability for initially unresectable malignant peritoneal mesothelioma (MPM). ...
MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma [0.03%]
PIPAC与全身化疗联合应用对比单独使用全身化疗作为恶性腹膜间皮瘤一线治疗的多中心随机二期临床试验（MESOTIP）
Olivia Sgarbura,Sophie Gourgou,Diego Tosi et al.
Olivia Sgarbura et al.
Background: Malignant peritoneal mesothelioma (MPM) is a rare tumoral disease characterized by the diffuse involvement of the peritoneal serosa. The standard frontline treatment of MPM is cytoreductive surgery with hypert...
Maher Tabba
Maher Tabba
Maher Tabba
Maher Tabba